Visual problems Eye pain, redness, or vision changes could signal increased eye pressure (angle-closure glaucoma)
Less common but important risks include dehydration, gallbladder problems, pancreatitis, worsening diabetic eye disease in some patients with rapid glucose improvement, and low blood sugar when used with insulin or sulfonylureas
If this happens consistently, you may find yourself not losing weight on semaglutide despite proper dosing
Similarly, abdominal exercises after an abdominal injection could theoretically increase local absorption speed
With this move, Novo Nordisk strengthens its GLP-1 portfolio in India, where it already markets Rybelsus (oral semaglutide) and Wegovy (obesity management)and enters a competitive space as Eli Lillys Mounjaro is also making inroads
This error compounds over the entire life of the vial, affecting every dose, not just one